Hims & Hers reverses plan for oral Wegovy, and its stock tumbled 20%

Hims & Hers stock tumbled in early action on Monday after the U.S. company quickly reversed plans to introduce its own version of Novo Nordisk’s Wegovy oral weight-loss drug.
Article Attribution | Read More at Article Source
The post Hims & Hers reverses plan for oral Wegovy, and its stock tumbled 20% appeared first on RocketNews.